期刊
IMMUNITY
卷 49, 期 6, 页码 1132-+出版社
CELL PRESS
DOI: 10.1016/j.immuni.2018.09.013
关键词
-
类别
资金
- NIH [R01CA207177, R01CA172025, R01CA192642, R01CA218254]
- Japan Society for the Promotion of Science Postdoctoral Fellowship for Research Abroad
- Crohn's & Colitis Foundation of America
Serrated adenocarcinoma, an alternative pathway for colorectal cancer (CRC) development, accounts for 15%-30% of all CRCs and is aggressive and treatment resistant. We show that the expression of atypical protein kinase C zeta (PKC zeta) and PKC lambda/iota was reduced in human serrated tumors. Simultaneous inactivation of the encoding genes in the mouse intestinal epithelium resulted in spontaneous serrated tumorigenesis that progressed to advanced cancer with a strongly reactive and immunosuppressive stroma. Whereas epithelial PKC lambda/iota deficiency led to immunogenic cell death and the infiltration of CD8(+) T cells, which repressed tumor initiation, PKC sigma loss impaired interferon and CD8(+) T cell responses, which resulted in tumorigenesis. Combined treatment with a TGF-beta receptor inhibitor plus anti-PD-L1 checkpoint blockade showed synergistic curative activity. Analysis of human samples supported the relevance of these kinases in the immunosurveillance defects of human serrated CRC. These findings provide insight into avenues for the detection and treatment of this poor-prognosis subtype of CRC.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据